1. Home
  2. GDTC vs VBIX Comparison

GDTC vs VBIX Comparison

Compare GDTC & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • VBIX
  • Stock Information
  • Founded
  • GDTC 2018
  • VBIX N/A
  • Country
  • GDTC Singapore
  • VBIX Israel
  • Employees
  • GDTC N/A
  • VBIX N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • VBIX Computer Software: Prepackaged Software
  • Sector
  • GDTC Health Care
  • VBIX Technology
  • Exchange
  • GDTC Nasdaq
  • VBIX Nasdaq
  • Market Cap
  • GDTC 28.0M
  • VBIX 26.4M
  • IPO Year
  • GDTC 2023
  • VBIX N/A
  • Fundamental
  • Price
  • GDTC $2.17
  • VBIX $4.71
  • Analyst Decision
  • GDTC Buy
  • VBIX
  • Analyst Count
  • GDTC 1
  • VBIX 0
  • Target Price
  • GDTC $5.00
  • VBIX N/A
  • AVG Volume (30 Days)
  • GDTC 5.7K
  • VBIX 117.1K
  • Earning Date
  • GDTC 01-01-0001
  • VBIX 08-14-2025
  • Dividend Yield
  • GDTC N/A
  • VBIX N/A
  • EPS Growth
  • GDTC N/A
  • VBIX N/A
  • EPS
  • GDTC N/A
  • VBIX N/A
  • Revenue
  • GDTC $368,838.00
  • VBIX $19,672,000.00
  • Revenue This Year
  • GDTC $5.37
  • VBIX N/A
  • Revenue Next Year
  • GDTC N/A
  • VBIX N/A
  • P/E Ratio
  • GDTC N/A
  • VBIX N/A
  • Revenue Growth
  • GDTC N/A
  • VBIX N/A
  • 52 Week Low
  • GDTC $1.20
  • VBIX $0.18
  • 52 Week High
  • GDTC $4.05
  • VBIX $12.00
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 47.12
  • VBIX N/A
  • Support Level
  • GDTC $2.07
  • VBIX N/A
  • Resistance Level
  • GDTC $2.34
  • VBIX N/A
  • Average True Range (ATR)
  • GDTC 0.10
  • VBIX 0.00
  • MACD
  • GDTC -0.00
  • VBIX 0.00
  • Stochastic Oscillator
  • GDTC 41.00
  • VBIX 0.00

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

Share on Social Networks: